CD36 is a low‐affinity receptor which recognizes the type I repeats of TSP‐1 and is reported to be an activator of the apoptotic pathways in ECs and some cancer cells.114, 115, 116 The first TSP‐1‐based therapeutic (ABT‐510) was developed based on this interaction more than a decade ago. This evidence concerns the gene CD36 and cancer.